MENU
RCUS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Arcus Biosciences (RCUS) Earnings Date & Reports

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

RCUS is expected to report earnings to -103 cents per share on May 13

Arcus Biosciences RCUS Stock Earnings Reports
Q1'25
Est.
$-1.04
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.95
The last earnings report on February 25 showed earnings per share of -102 cents, beating the estimate of -123 cents. With 1.58M shares outstanding, the current market capitalization sits at 995.97M.
View a ticker or compare two or three
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com